These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15561080)
1. Time to move beyond retrospective analyses for thymic neoplasms and conduct a prospective multi-institutional clinical trial. Thomas CR Ann Thorac Surg; 2004 Dec; 78(6):2207; author reply 2207-8. PubMed ID: 15561080 [No Abstract] [Full Text] [Related]
2. [Radiotherapy of thymomas]. Guérin RA Rev Mal Respir; 1988; 5(2):167-71. PubMed ID: 3134677 [TBL] [Abstract][Full Text] [Related]
3. [Thymic tumors]. Le Péchoux C; Mahé M; Bretel JJ; Roberti E; Ruffié P Cancer Radiother; 2005 Nov; 9(6-7):351-7. PubMed ID: 16168694 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Kundel Y; Yellin A; Popovtzer A; Pfeffer R; Symon Z; Simansky DA; Oberman B; Sadezki S; Brenner B; Catane R; Levitt ML Am J Clin Oncol; 2007 Aug; 30(4):389-94. PubMed ID: 17762439 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for thymoma and thymic carcinoma. Fuller CD; Housman DM; Thomas CR Hematol Oncol Clin North Am; 2008 Jun; 22(3):489-507. PubMed ID: 18514129 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiation with modern techniques is the standard of care for stage III thymoma. Cesaretti JA Ann Thorac Surg; 2006 Mar; 81(3):1180-1; author reply 1181-2. PubMed ID: 16488766 [No Abstract] [Full Text] [Related]
7. Postoperative proton therapy in the management of stage III thymoma. Figura N; Hoppe BS; Flampouri S; Su Z; Osian O; Monroe A; Nichols RC J Thorac Oncol; 2013 May; 8(5):e38-40. PubMed ID: 23584300 [No Abstract] [Full Text] [Related]
8. A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma. Hamaji M; Shah RM; Ali SO; Bettenhausen A; Lee HS; Burt BM Ann Thorac Surg; 2017 May; 103(5):1668-1675. PubMed ID: 28366466 [TBL] [Abstract][Full Text] [Related]
9. Vitiligo at the site of radiotherapy for malignant thymoma. Kim DH; Kim CW; Kim TY Acta Derm Venereol; 1999 Nov; 79(6):497. PubMed ID: 10598784 [No Abstract] [Full Text] [Related]
10. Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma. Azad A; Herbertson RA; Pook D; White S; Mitchell PL; Tebbutt NC Acta Oncol; 2009; 48(4):619-21. PubMed ID: 18979266 [No Abstract] [Full Text] [Related]